PARIS The Paris prosecutor's office said on Wednesday that drugmaker Servier as well as the French drug regulator should face trial over weight-loss pill Mediator, believed to have caused at least 500 deaths in one of France's worst health scandals.
Once licensed as a diabetes treatment, the drug was widely prescribed as an appetite suppressant to help people lose weight.
Mediator, whose active chemical substance is known as Benfluorex, was withdrawn from the French market in 2009, around a decade after being pulled in Spain, Italy and the United States.
The prosecutor's indictment covers charges of misleading claims as well as manslaughter and targets 14 people as well as 11 institutions including Servier and the French drug regulator ANSM.
A spokeswoman with Servier had no comment.
According to the health ministry, at least 500 people died of heart valve trouble in France because of exposure to Mediator's active ingredient. Other estimates based on extrapolations have put the death toll closer to 2,000.
(Reporting by Simond Carraud, Matthias Blamont and Emmanuel Jarry; Editing by Leigh Thomas)
WASHINGTON U.S. Senate Majority Leader Mitch McConnell said on Wednesday he does not yet know how Republicans will amass the votes needed to pass legislation now being crafted to dismantle Obamacare, but expressed some optimism on another top priority, overhauling the tax code.
LONDON GW Pharmaceuticals is set to file its cannabis-derived drug with U.S. regulators imminently, following publication of detailed data on its success in fighting severe childhood epilepsy.
An experimental foot-temperature monitoring system might one day be able to detect when diabetic patients are developing foot ulcers, a common complication that can lead to infections and amputations, a small study suggests.
See more here:
French drugmaker Servier to face trial over weight-loss Mediator - Reuters
